Statistics in Biopharmaceutical Research

Papers
(The H4-Index of Statistics in Biopharmaceutical Research is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
U-MET: Utility-Based Dose Optimization Approach for Multiple-Dose Randomized Trial Designs30
Predicting Probability of Success for Phase III Trials via Propensity-Score-Based External Data Borrowing21
DODII: Bayesian Dose Optimization Design for Randomized Phase II Trials19
Statistical Inference of the Probability of Passing the USP Dissolution Test14
Treatment Selection at Interim Analysis Based on a Correlated Early Endpoint in Adaptive Two-Stage Trials with a Primary Endpoint Based on Count Data14
Joint Analysis of Longitudinal Ordinal Categorical Item Response Data and Survival Times with Cure Fraction11
Missing Data Imputation for a Multivariate Outcome of Mixed Variable Types11
Consistency Based Multiplicity Adjustment Approach—Multiple Doses in Phase III Studies10
Design Strategy and Consideration for Oncology Dose-Optimization: An Industry Perspective10
The Current Landscape of HTA Framework and Key Challenges10
Modified Simon’s Two-Stage Design for Phase IIA Clinical Trials in Oncology—Dynamic Monitoring and More Flexibility10
0.028057098388672